Nyxoah SA (NYXH)
NASDAQ: NYXH · Real-Time Price · USD
7.25
-0.21 (-2.82%)
At close: Aug 6, 2025, 4:00 PM
7.39
+0.14 (1.93%)
After-hours: Aug 6, 2025, 4:10 PM EDT
Sage Therapeutics Market Cap
Nyxoah has a market cap or net worth of $272.72 million as of August 6, 2025. Its market cap has decreased by -7.26% in one year.
Market Cap
272.72M
Enterprise Value
225.05M
1-Year Change
-7.26%
Ranking
Category
Stock Price
$7.25
Market Cap Chart
Since the IPO on February 9, 2021, Nyxoah's market cap has decreased from $506.14M to $272.72M, a decrease of -46.12%. That is a compound annual growth rate of -12.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 287.37M | -10.22% |
| Dec 31, 2024 | 320.06M | 137.05% |
| Dec 29, 2023 | 135.02M | -4.90% |
| Dec 30, 2022 | 141.98M | -73.96% |
| Dec 31, 2021 | 545.17M | 7.71% |
| Feb 9, 2021 | 506.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| Novartis AG | 228.98B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novo Nordisk | 210.71B |